Skip to main content
. Author manuscript; available in PMC: 2016 Mar 22.
Published in final edited form as: Clin Cancer Res. 2007 Dec 1;13(23):7133–7138. doi: 10.1158/1078-0432.CCR-07-0874

Table 3.

Reported dose-limiting toxicities

Toxicity Irinotecan dose, mg/m2 (no. of patients treated)
350 (6) 400 (3) 450 (3) 500 (6) 500 (12)* 550 (2)
Diarrhea 0 0 0 1 0 1
Granulocytopenia 0 0 0 0 0 0
Lymphocytopenia 0 0 0 0 0 0
Leukopenia 0 0 0 0 0 0
Nausea/vomiting 1 0 0 0 0 1

NOTE: No instances of grade 4 toxicity were reported.

*

Expansion cohort of 12 patients accrued to further assess the irinotecan toxicity profile.